Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase NA 22Phase 3 8Phase 1/2 6Phase 4 5Phase 2/3 3Phase EARLY_PHASE1 2Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Neoplasms 1Fatigue 1

Interventions

pembrolizumab 7Cyclophosphamide 5Metformin 4durvalumab 3Vincristine 3Radiation 3Imiquimod 3Fluorouracil 3antitumor A 2Testosterone 2Surveys and Questionnaires 2Rituximab 2Prednisone 2Positron Emission Tomography Computed Tomography 2Oxaliplatin 2Leucovorin 2Lapatinib 2Immunoglobulin G 2HhAntag691 2Doxorubicin 2Disulfides 2Cisplatin 2Biopsy 2xentuzumab 1tremelimumab 1ribociclib 1posaconazole 1pexidartinib 1perflutren 1pazopanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Has results × Surveys and Questionnaires × Clear all
NCT04495751 2025-10-16

Muscadine Grape Extract to Improve Fatigue

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Completed
64 enrolled 17 charts

Fatigue, Neoplasms

NCT02411565 2019-01-23

Fermented Wheat Germ Extract in Women With Ovarian Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Terminated
3 enrolled 7 charts
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡